States / New York / A 5285

A 5285 Enacted

Relates to prescription labels for mifepristone and misoprostol

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Chamber
House
Introduced
Feb 12, 2025
Last action
Mar 20, 2025 — SIGNED CHAP.108
Session
2025-2026
Momentum
81 · Very high